(Q48591391)

13 February 2018

title

Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department. (English)

1 reference

13 February 2018

David Herd

1

0 references

Brian Anderson

series ordinal

2

object named as

Brian J Anderson

1 reference

13 February 2018

publication date

1 July 2007

1 reference

13 February 2018

published in

Paediatric Anaesthesia

1 reference

13 February 2018

volume

17

1 reference

13 February 2018

issue

7

1 reference

13 February 2018

page(s)

622-629

1 reference

13 February 2018

Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Prolonged pre-procedure fasting time is unnecessary when using titrated intravenous ketamine for paediatric procedural sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

The Lancaster experience of 2.0 to 2.5 mg/kg intramuscular ketamine for paediatric sedation: 501 cases and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Procedural sedation in paediatric minor procedures: a prospective audit on ketamine use in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Ketamine for paediatric sedation/analgesia in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Ketamine is not a safe, effective, and appropriate technique for emergency department paediatric procedural sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Ketamine is a safe, effective, and appropriate technique for emergency department paediatric procedural sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Pharmacokinetics and analgesic effect of ketamine in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Ketamine disposition in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Scaling for size: some implications for paediatric anaesthesia dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

A general model for the origin of allometric scaling laws in biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

The fourth dimension of life: fractal geometry and allometric scaling of organisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Ketamine infusions: pharmacokinetics and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Pharmacokinetics of ketamine and its metabolite, norketamine, after intravenous administration of a bolus of ketamine to isoflurane-anesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Age and size are the major covariates for prediction of levobupivacaine clearance in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Limited predictability of amikacin clearance in extreme premature neonates at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Measuring anesthesia in children using the EEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9592.2006.02145.X

10.1111/J.1460-9592.2006.02145.X

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018